Barclays Bank of Botswana Limited (BARC.bw) 2013 Annual Report

first_imgABSA Bank of Botswana Limited (ABBL.bw) listed on the Botswana Stock Exchange under the Banking sector has released it’s 2013 annual report.For more information about ABSA Bank of Botswana Limited (ABBL.bw) reports, abridged reports, interim earnings results and earnings presentations, visit the ABSA Bank of Botswana Limited (ABBL.bw) company page on AfricanFinancials.Document: ABSA Bank of Botswana Limited (ABBL.bw)  2013 annual report.Company ProfileAbsa Bank of Botswana Limited formerly (Barclays Bank of Botswana Limited) is an established financial services group; providing solutions in the retail, commercial and corporate sector in Botswana. The group has a national footprint, with 34 branches and 75 ATMs located in the major towns and cities of Botswana. Its personal banking products and services range from savings and fixed deposits to graduate loans, funeral cover and smart phone banking services. Its business banking division provides the standard solutions for commercial and corporate transactions, investments and loans, as well as an array of specialised financial solutions such as treasury services, foreign exchange and currency repo, risk management and trade finance products. Absa Bank of Botswana Limited is a subsidiary of Barclays Africa Group Limited.last_img read more

I&M Bank (Rwanda) Limited (IM.rw) Q12019 Interim Report

first_imgI&M Bank (Rwanda) Limited (IM.rw) listed on the Rwanda Stock Exchange under the Banking sector has released it’s 2019 interim results for the first quarter.For more information about I&M Bank (Rwanda) Limited (IM.rw) reports, abridged reports, interim earnings results and earnings presentations, visit the I&M Bank (Rwanda) Limited (IM.rw) company page on AfricanFinancials.Document: I&M Bank (Rwanda) Limited (IM.rw)  2019 interim results for the first quarter.Company ProfileI&M Bank (Rwanda) Limited is a leading financial institution in Rwanda offering products and services for the retail, commercial and corporate banking segment. Personal banking products range from current accounts and short or fixed deposits to personal, vehicle, home and building loans. The corporate division offers financial solutions for sole proprietorships, partnerships and corporations which range from overdrafts, investments and equipment and vehicle loans to purchase and disposal of foreign currency and treasury services. This includes issuing letters of credit and guarantee, export and import trading, insurance premium financing, and e-banking services. I&M Bank (Rwanda) Limited is a subsidiary of I&M Bank Limited and is based in Kigali, Rwanda. I&M Bank (Rwanda) Limited is listed on the Rwanda Stock Exchangelast_img read more

I’d buy GlaxoSmithKline at its current share price

first_img I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Image source: Getty Images. “This Stock Could Be Like Buying Amazon in 1997” Simply click below to discover how you can take advantage of this. Our 6 ‘Best Buys Now’ Shares See all posts by James J. McCombie Since I last wrote about why I am a buyer of GlaxoSmithKline (LSE:GSK) shares, their price has risen by about 8%. The Glaxo stock price is, however, still down about 14% over the last 12 months. There is also the fact that it is trading at early 2018 prices. James J. McCombie owns shares of GlaxoSmithKline, Reckitt Benckiser and Unilever. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Enter Your Email Address It looks like the GlaxoSmithKline share price swings between about 1,300p and 1,750p. Glaxo has paid a steady 80p dividend since 2015, so the dividend yield has swung between 6% and 4%. It appears that dividend yield is important to Glaxo shareholders.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…GlaxoSmithKline dividend cutWhen looking for answers to why the GlaxoSmithKline share price broke through the 1,300p level and has not started to make its usual turnaround, I need only to look to recent dividend news.Glaxo expects to pay an 80p dividend in 2021. However, a new policy is being put into action from 2022 onwards.  Management has warned shareholders that aggregate dividend payments will likely fall. The analyst consensus estimate for the 2022 Gaxo dividend is 67p. And, it will be an aggregate dividend because Glaxo plans to split into two companies in 2022.GlaxoSmithKline splitBig shareholders in Glaxo have argued that selling toothpaste has little in common with making vaccines and prescription drugs. Now it appears their wish has been granted. Glaxo is set to split into two companies in 2022. The first, dubbed ‘New Glaxo’, will be a biopharma company. The second will be the consumer healthcare business.The consumer healthcare business is a cash cow. Once separated, it can be leveraged to a more appropriate capital structure. Free of the cash-hungry biopharma business dividends have scope to increase.The New Glaxo will get a cash injection and rid itself of a chunk of debt. The New Glaxo is likely to be a riskier company without the steady cash flows of the consumer healthcare business and will be spending heavily on R&D; dividends will likely be negligible and uncertain for some time.Repricing GlaxoSmithKline sharesOf the 99 profitable pharmaceutical companies worth more than £1bn domiciled in G7 economies, Glaxo has the ninetieth lowest price-to-earnings ratio at 11. Post-split, I believe the consumer healthcare business could be priced more in line with consumer brands companies like Unilever and Reckitt Benckiser, who trade at 22 and 46 times earnings, respectively.New Glaxo will be the beneficiary of a concerted effort to ramp up R&D and acquisitions over recent years. For example, New Glaxo will inherit a potentially game-changing long-acting HIV medicine that has been approved in the US and the ‘adjuvant’ technology platform that boosts responses to vaccinations. It might be late to the party, but Glaxo is collaborating on several coronavirus vaccines that, if approved, will be in demand for some time. I can see the New Glaxo benefitting from a repricing to a growth-orientated company. There are plansIf Glaxo can restructure and hive off two new businesses without letting costs mount up, then I believe I will be a happy investor in the long term. The aggregate risk probably increases with the two new companies. But, I have confidence that the Glaxo share price can break the cycle of bouncing between prices that imply a four to six per cent dividend yield by splitting in two. I’d buy GlaxoSmithKline at its current share price Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! James J. McCombie | Saturday, 27th March, 2021 | More on: GSK Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee.last_img read more

5 FTSE 100 stocks I’d buy today

first_img Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Nadia Yaqub | Friday, 21st May, 2021 Image source: Getty Images Our 6 ‘Best Buys Now’ Shares I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Nadia Yaqub has no position in any of the companies mentioned. The Motley Fool UK has recommended Diageo, Lloyds Banking Group, and Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Enter Your Email Addresscenter_img 5 FTSE 100 stocks I’d buy today See all posts by Nadia Yaqub Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! “This Stock Could Be Like Buying Amazon in 1997” Simply click below to discover how you can take advantage of this. The FTSE 100 has some great companies in its ranks. The UK’s leading stock index may be hovering round the 7,000 mark but here are five FTSE 100 stocks I’d buy today.#1 – SageAccountancy software specialist Sage recently announced its half-year results. And the numbers showed strong momentum with encouraging organic revenue growth of 4.4%.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…The FTSE 100 firm is undergoing a transformation. It’s migrating its customers to cloud-based software. It’s also placing a focus on recurring revenue. And if there’s one thing investors love, it’s sales predictability. This should boost the share price going forward.It’s worth noting that the transition to a subscription business model will take time. Sage is also likely to incur extra costs, which may impact profitability.#2 – DiageoDiageo is my FTSE 100 reopening stock pick. It has a diversified beverage portfolio of over 200 brands. And as lockdowns start to ease, more people are likely to dine and drink out. This should help the company’s revenue and profitability.It recently announced that it’s going to be returning capital to shareholders through share buybacks. This sounds encouraging and indicates to me that Diageo’s financial position has improved.But the shares are still sensitive to any Covid-19 setbacks. And there’s no guarantee the return of capital will continue if conditions deteriorate.#3 – Rolls-RoyceLast year was a horrendous one for Rolls-Royce, but I think the worst is behind it now. The vaccination rollout has been going well and travelling abroad now looks likely.Management expects the company’s cash flow to turn positive in the second half of 2021. This is encouraging news. Rolls-Royce also has seen robust earnings from its Defence division, which it expects to continue.But again, any ongoing Covid-19 issues are likely to hit the FTSE 100 stock and the business.#4 – LloydsLloyds is in a better financial position now than in the dark days of the financial crisis. Its 2021 strategy is to build out its small business offering as well as to focus on large corporates and institutional clients. Such a diverse customer base should improve and diversify the bank’s revenue prospects.I think Lloyds has weathered the coronavirus storm well.  The bank had to cancel its dividend due to pressure from the financial regulator. As the UK economy improves, I think a reinstatement of the dividend could be on the cards.But headwinds remain. The bank still depends on interest rates to make money, which are at rock bottom and I don’t expect them to rise any time soon. This could impact profitability going forward.#5 – WhitbreadI’m not surprised that Whitbread was a victim of the pandemic. After all, it’s the owner and operator of the budget hotel chain, Premier Inn.As the economy starts to open up, people are likely to travel more. If not abroad, then a staycation or business trip in the UK is a possibility. Whitbread is well positioned to capitalise on this opportunity. It has a strong brand and a good reputation for offering value.But the shares and the business could be hit by any delays in the easing of lockdown restrictions. Further coronavirus variants could also derail its recovery.last_img read more

Google expands its nonprofit programme

first_imgGoogle has expanded its nonprofit programme, by which it helps charities and nonprofits in several countries to make the most of some of its products and tools. It has also simplified the registration process to cover all of the opportunities with a single registration.The programme offers:* up to $10,000 a month in advertising on Google AdWords to reach more donors or supporters* free or discounted Google Apps “to cut IT costs and operate more efficiently”* premium features for YouTube and Google Mapping to raise awareness of causes.The single registration means that organisation will no longer have to apply separately for Google Grants, the YouTube Nonprofits programme, and other elements.Elements of the programme, such as the AdWords and YouTube programmes, have been available to UK charities for several years. But the revamped Google Nonprofits programme is not yet available to UK charities.Google will also be offering more educational videos and case studies to help organisations make the most of its tools. It has also created a Nonprofits Marketplace which lists agencies and partners that offer training or consulting in these tools for free or at discounted rates for charities. These firms are already certified partners from existing Google marketplaces—like AdWords Authorised Resellers, Analytics Certified Partners, Google Apps Marketplace and the Google Earth Outreach Developer Marketplace.The Google for Nonprofits blog cites examples of nonprofits that have achieved impressive results using its tools.These include Direct Relief International which raised more than $1,000,000 with AdWords, the Natural Resource Defense Council which attracted over 100,000 views on their YouTube videos at the time of the BP oil spill last year, and Samasource’s success in saving tens of thousands of dollars using Google Apps.www.google.com/nonprofits  62 total views,  4 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Howard Lake | 22 March 2011 | News  61 total views,  3 views today Advertisement Google expands its nonprofit programme Tagged with: corporate Digital donated services Technologylast_img read more

NASA’s Europa Mission Gets a Launch Date

first_imgHome of the Week: Unique Pasadena Home Located on Madeline Drive, Pasadena Subscribe A mission to study Europa, a moon of Jupiter that could be home to extraterrestrial life, has been given a launch date.NASA is sending a spacecraft to the icy world, which holds an ocean under its frozen outer shell.Scientists have long regarded the moon as one of the most promising targets in the search for life elsewhere in our Solar System.The Europa Clipper spacecraft will now launch to the Jovian moon in October 2024, arriving in April 2030.The spacecraft, according to the BBC News, was to have launched on NASA’s Space Launch System (SLS) rocket. But the space agency is reported to no longer be considering that launch vehicle.It will instead lift off on a commercial rocket.The details were disclosed by the mission’s project scientist, Dr. Robert Pappalardo, during a virtual meeting of NASA’s Outer Planets Assessment Group (OPAG).“We now have clarity on the launch vehicle path and launch date,” Pappalardo, who is based at the space agency’s Jet Propulsion Laboratory in Pasadena, told the meeting.Interest in the moon as a potential habitat for extraterrestrial life was given a boost in the 1990s when the Galileo spacecraft provided evidence that Europa harbored an ocean of liquid water beneath its outer shell.Europa probably has a rocky core surrounded by around 50 miles of liquid water covered by a shell of water-ice that’s roughly 12 miles thick.“Europa’s about the size of Earth’s moon, yet we think it contains twice as much water as all of Earth’s oceans,” Pappalardo said during a virtual talk organized by Arizona State University (ASU) last week.Discussing the moon’s potential for life, he said: “At the bottom of the Earth’s oceans are places where water and rock interact, where water seeps down, contacts hot rock and emerges charged with chemical nutrients — reductants.”When these reductants get together with other chemicals called oxidants, they react, he explained.Pappalardo said these reactions could, “potentially power life at the ocean floor of Europa — even where there is no light to allow for photosynthesis.”The spacecraft will be able to analyze chemicals in frozen water that has welled up to the surface from beneath the ice shell. It might also be able to sample the contents of water plumes that seem to be spurting out into space from locations on the Jovian moon. Make a comment STAFF REPORT First Heatwave Expected Next Week Science and Technology NASA’s Europa Mission Gets a Launch Date Courtesy of JPL Published on Thursday, February 11, 2021 | 2:47 pm Name (required)  Mail (required) (not be published)  Website  65 recommended0 commentsShareShareTweetSharePin it CITY NEWS SERVICE/STAFF REPORT Pasadena Will Allow Vaccinated People to Go Without Masks in Most Settings Starting on Tuesday Business News Community Newscenter_img Get our daily Pasadena newspaper in your email box. Free.Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m. More Cool Stuff Your email address will not be published. Required fields are marked * HerbeautyThese Are 15 Great Style Tips From Asian WomenHerbeautyHerbeautyHerbeautyHe Is Totally In Love With You If He Does These 7 ThingsHerbeautyHerbeautyHerbeautyWhat Is It That Actually Makes French Women So Admirable?HerbeautyHerbeautyHerbeautyAncient Beauty Remedies From India To Swear By For Healthy SkinHerbeautyHerbeautyHerbeautyWhat’s Your Zodiac Flower Sign?HerbeautyHerbeautyHerbeautyWant To Seriously Cut On Sugar? You Need To Know A Few TricksHerbeautyHerbeauty faithfernandez More » ShareTweetShare on Google+Pin on PinterestSend with WhatsApp,Virtual Schools PasadenaHomes Solve Community/Gov/Pub SafetyCitizen Service CenterPASADENA EVENTS & ACTIVITIES CALENDARClick here for Movie Showtimes STAFF REPORT Pasadena’s ‘626 Day’ Aims to Celebrate City, Boost Local Economy Community News EVENTS & ENTERTAINMENT | FOOD & DRINK | THE ARTS | REAL ESTATE | HOME & GARDEN | WELLNESS | SOCIAL SCENE | GETAWAYS | PARENTS & KIDS Top of the News last_img read more

NORTH AMERICAN HOCKEY LEAGUE: Jackalopes fall in overtime for second straight game

first_img Twitter WhatsApp NORTH AMERICAN HOCKEY LEAGUE: Jackalopes fall in overtime for second straight game Odessa Jackalopes logo SHREVEPORT, LA. The Odessa Jackalopes jumped out to an early lead Saturday but suffered the same fate as the night before, falling 3-2 in overtime to Shreveport at the George’s Pond Hirschi Coliseum.The Jackalopes (4-5-2-0 overall) jumped out to a 2-0 lead after the first period with goals from Joey Musa and Ben Doherty. The Mudbugs (8-1-1-0) responded with a second-period goal by Matt Weber and tied the game late in the third period with Dilan Peters.Dawson Scirrano’s goal at 3:23 in overtime was the game-winner.The Jackalopes return home for a series against the Lone Star Brahamas starting Thursday at Ector County Coliseum. Facebook By Digital AIM Web Support – December 13, 2020 Pinterest Previous articleWoman returns favor 30 years laterNext articleBARTLETT, CHARLOTTE .jpeg Digital AIM Web Supportcenter_img TAGS  Facebook SportsJackalopesLocal News WhatsApp Twitter Pinterestlast_img read more

Differing Donegal perspectives on Royal visit

first_img RELATED ARTICLESMORE FROM AUTHOR Differing Donegal perspectives on Royal visit Donegal North East Deputy Padraig Mac Lochlainn has hit out at people who rioted and attacked gardai in Dublin last evening on the fringes of the Royal Visit, but says that is not to take away from the legitimate concerns people have about this visit.On the issue of an apology, or whatever words Queen Elizabeth may choose to use when she speaks at a state dinner in Dublin Castle tonight, there needs to be an acknowledgement of the role British Intelligence played in helping plan a number of loyalist atrocities……..[podcast]http://www.highlandradio.com/wp-content/uploads/2011/05/pmacl.mp3[/podcast]Meanwhile, Junior MInister Dinny Mc Ginley was chosen as one of five Ministers of State to meet the Queen and Prince Philip when they visited government buildings.The Donegal South West Deputy says it was an honour……….[podcast]http://www.highlandradio.com/wp-content/uploads/2011/05/din.mp3[/podcast] Facebook Pinterest WhatsApp Gardai continue to investigate Kilmacrennan fire Further drop in people receiving PUP in Donegal Pinterest Facebook Newsx Adverts Google+center_img Man arrested on suspicion of drugs and criminal property offences in Derry Main Evening News, Sport and Obituaries Tuesday May 25th By News Highland – May 18, 2011 365 additional cases of Covid-19 in Republic WhatsApp Previous articleSoccer – Harps move to Saturday Night footballNext articleTwo injured in Strabane attack News Highland Twitter Twitter 75 positive cases of Covid confirmed in North Google+last_img read more

Delhi High Court Seeks Union’s Health Budget Details, Crowdfunding Proposals On Petition For Treatment of Rare Diseases

first_imgNews UpdatesDelhi High Court Seeks Union’s Health Budget Details, Crowdfunding Proposals On Petition For Treatment of Rare Diseases Shreya Agarwal6 March 2021 1:34 AMShare This – xHearing a petition for children suffering from rare diseases like Duchenne Muscular Dystrophy (DMD), Hunter’s syndrome, et al the Delhi High Court has directed the Centre to state on affidavit its budget for health in the last 5 years and if any unused budget can be used for the treatment of the petitioners or development of therapies for treatment of rare diseases.The court has directed…Your free access to Live Law has expiredTo read the article, get a premium account.Your Subscription Supports Independent JournalismSubscription starts from ₹ 599+GST (For 6 Months)View PlansPremium account gives you:Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.Subscribe NowAlready a subscriber?LoginHearing a petition for children suffering from rare diseases like Duchenne Muscular Dystrophy (DMD), Hunter’s syndrome, et al the Delhi High Court has directed the Centre to state on affidavit its budget for health in the last 5 years and if any unused budget can be used for the treatment of the petitioners or development of therapies for treatment of rare diseases.The court has directed a nine-member Committee constituted by it, to submit a report on proposals for crowdfunding of the costs of treatment for children with rare diseases.The committee has further been directed to look into various related issues in its report, including – providing of urgent treatment and therapy options to patients, steps for indigenization of the development of the therapies, reasonable timelines to be followed, accelerated approval processes for current Indian researches on the diseases.While the centre’s response on the idea of crowdfunding was that it couldn’t be undertaken until a dedicated e-platform was set up for the purpose, the representative of the Ministry of Health informed the court orally that a communication had been sent to 4 organisations to arrange for funding of the treatment of the patients in question.The court directed the Union to consider accelerated approvals to the current research on DMD therapies, and said that it ought to explore the confidential proposal put forward by one M/s Sarepta Therapeutics to make the therapies available for children.Earlier, the court had remarked, “Just because of the exorbitant price of the drug or treatment, patients, especially children, suffering from a rare disease ought not to be deprived of treatment for their condition.”The Court, through a common judgment in the two petitions, had issued directions to the Union of India, Ministry of Health and Family Welfare to finalize the implementation of Draft Health Policy for Rare Diseases, 2020 at the earliest.The petitioners had contended that due to the exorbitant prices involved in the treatment, the government must provide free treatment to them as the disease fall well within the draft policy which is at the consultation stage at present.The Court had also directed the Union of India to implement and notify the draft policy and also consider crowd funding option in the meantime for the successful treatment of the petitioners.The petitions have been filed by natural guardians of two children suffering from a rare disease known as Duchenne Muscular Dystrophy (DMD). According to the petitioners, due to the rarity of the disease, its drug was being manufactured by a US-based company called Sarepta Therapeutics, because in India, the drug was presently in its experimental stage.The petitioners, being aggrieved by the exorbitantly expensive prices of the drug, filed petitions in the High Court seeking directions on the Union of India, Ministry of Health and Family Welfare to ensure that the petitioners are given free treatment for the disorder as they could not afford the heavy prices at which the drug was being soldSubscribe to LiveLaw, enjoy Ad free version and other unlimited features, just INR 599 Click here to Subscribe. All payment options available.loading….Next Storylast_img read more

Santa Anita to continue racing because reforms are ‘working,’ spokesman says

first_img Beau Lund Written by June 10, 2019 /Sports News – National Santa Anita to continue racing because reforms are ‘working,’ spokesman sayscenter_img FacebookTwitterLinkedInEmailMario Tama/Getty Images)(LOS ANGELES) — Santa Anita Park will not heed the California Horse Racing Board’s recommendation to suspend racing in the wake of two more horse deaths over the weekend because the reforms that were enacted earlier in the year appear to be effective, according to a spokesman. In March, the park announced a series of changes surrounding horse safety, including a “zero tolerance” policy for the use of medication on racing day in the wake of more than two dozen horse deaths since December 2018.The California Horse Racing Board further voted to limit whips on racing day as well, a rule that applies to Santa Anita.After the reforms took place, the park saw up to seven weeks of “clean racing,” Stefan Friedman, spokesman for The Stronach Group, a company that owns the park, told ABC News. In addition, the track has seen 50% fewer catastrophic breakdowns during racing and 84% fewer catastrophic incidents during training, Friedman said.There were no horse fatalities between April 1 to May 18, when the death toll remained at 23, Santa Anita said in a statement last month. But after that time, the number of horses dying began to climb once again.On Sunday, 3-year-old Truffalino collapsed in the final stages of the third race and died of a heart attack, Friedman said. The day before, 4-year-old Formal Dude broke down while nearing the finish line in the 10th race and was euthanized, he said.A total of 29 horses have died at Santa Anita since the start of the racing season.The chairman, vice chairman and executive director of the California Horse Racing Board recommended on Saturday that Santa Anita suspend racing for the seven remaining race days of 2019, which lasts until June 23, but continue training during that time period, according to a statement from Mike Marten, the board’s public information officer.“It is our understanding that Santa Anita management, after consultation with certain other industry stakeholders, believes that for a variety of reasons, the future of California racing is best served by continuing to race,” the California Horse Racing Board said in a statement over the weekend.Under current California law, the board does not have the authority to suspend a race meet or remove race dates without the approval of the race track operator or without holding a public meeting with 10 days’ notice, Marten said. Santa Anita’s decision to stay open was made after and “extensive consultation” among the The Stronach Group, the Thoroughbred Owners of California and California Thoroughbred Trainers, according to a joint statement from those organizations.Friedman described the most recent horse deaths as “really devastating,” adding that the decision to continue racing “was not made lightly.” The park and the California Horse Racing Board have a “really good relationship,” Friedman added.“The reforms that we instituted are working,” Friedman said. “Do we have a lot more work to do? Absolutely. And everyone at this track, whether it’s the Stronach Group or the horsemen or the trainers or the jockeys, are fully on board and committed to the goal of having zero catastrophic breakdowns.”In April, PETA Senior Vice President Kathy Guillermo told ABC News that the animal rights advocacy group supported the new rules that Santa Anita put into place, calling them the “first step in what needs to be an overhaul in racing nationwide.”“The reason that we take that perspective is that the broken bones in California are happening all over the country,” Guillermo said, referring to horse injuries.Friedman argued that if Santa Anita were to shut down the track, it would be a “terrible signal to everyone that these reforms were ineffective, and that’s just not correct.”“Secondly…to shut down racing and essentially shut down training, you’re taking about closing down a facility and the horses,” Friedman said. “There’s no place for them to go in this juncture in California,” he added.Nearly 2,000 horses live on site and hundreds of Santa Anita employees live and work on site as well, Friedman said.Guillermo said in a statement Monday that what’s happening at Santa Anita is a “microcosm of what’s happening in racing nationally: broken bones, death and public outrage.”“Their bodies litter tracks in New York, Kentucky, Florida, Texas and many other states,” she said, adding that PETA recently called for tracks nationwide to suspend racing until they can implement “long-needed and significant changes that will help end the cruelty and protect horses.”Santa Anita Park will host the 2019 Breeders’ Cup world championships on Nov. 1 and 2.Copyright © 2019, ABC Radio. All rights reserved.last_img read more